Nwam LLC Novartis Ag Transaction History

Nwam LLC

$1.6 Billion
Q3 2024

A detailed history of Nwam LLC transactions in Novartis Ag stock. As of the latest transaction made, Nwam LLC holds 4,069 shares of NVS stock, worth $424,315. This represents 0.03% of its overall portfolio holdings.

Number of Shares

4,069

Holding current value

$424,315

% of portfolio

0.03%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$106.13 - $120.89 $431,842 - $491,901	4,069 New	4,069 $468,000
Q1 2024 May 09, 2024	SELL	$95.27 - $108.47 $61,449 - $69,963	-645 Reduced 15.18%	3,605 $348,000
Q4 2023 Feb 14, 2024	BUY	$92.27 - $101.54 $4,982 - $5,483	54 Added 1.29%	4,250 $429,000
Q3 2023 Oct 31, 2023	SELL	$94.73 - $105.13 $35,523 - $39,423	-375 Reduced 8.2%	4,196 $427,000
Q2 2023 Aug 09, 2023	BUY	$92.52 - $104.91 $62,913 - $71,338	680 Added 17.48%	4,571 $461,000
Q1 2023 May 12, 2023	SELL	$80.03 - $92.81 $45,697 - $52,994	-571 Reduced 12.8%	3,891 $357,000
Q4 2022 Feb 07, 2023	BUY	$75.55 - $92.52 $63,990 - $78,364	847 Added 23.43%	4,462 $404,000
Q3 2022 Nov 14, 2022	SELL	$74.61 - $87.26 $85,950 - $100,523	-1,152 Reduced 24.17%	3,615 $275,000
Q2 2022 Aug 10, 2022	BUY	$80.52 - $93.75 $108,782 - $126,656	1,351 Added 39.55%	4,767 $402,000
Q1 2022 May 12, 2022	BUY	$80.11 - $90.62 $5,287 - $5,980	66 Added 1.97%	3,416 $300,000
Q4 2021 Feb 10, 2022	BUY	$79.7 - $88.13 $64,078 - $70,856	804 Added 31.58%	3,350 $293,000
Q3 2021 Nov 03, 2021	SELL	$81.78 - $95.14 $18,073 - $21,025	-221 Reduced 7.99%	2,546 $208,000
Q2 2021 Aug 04, 2021	SELL	$85.24 - $94.15 $1,278 - $1,412	-15 Reduced 0.54%	2,767 $252,000
Q1 2021 Apr 23, 2021	BUY	$83.5 - $98.47 $2,254 - $2,658	27 Added 0.98%	2,782 $238,000
Q4 2020 Jan 22, 2021	BUY	$78.07 - $94.43 $215,082 - $260,154	2,755 New	2,755 $260,000
Q3 2020 Oct 16, 2020	SELL	$82.14 - $91.0 $226,952 - $251,433	-2,763 Closed	0 $0
Q2 2020 Jul 21, 2020	BUY	$80.93 - $91.1 $14,648 - $16,489	181 Added 7.01%	2,763 $241,000
Q1 2020 Apr 16, 2020	SELL	$70.67 - $99.01 $66,359 - $92,970	-939 Reduced 26.67%	2,582 $213,000
Q4 2019 Jan 23, 2020	SELL	$84.35 - $95.37 $32,052 - $36,240	-380 Reduced 9.74%	3,521 $333,000
Q3 2019 Oct 15, 2019	BUY	$85.54 - $94.26 $56,541 - $62,305	661 Added 20.4%	3,901 $339,000
Q2 2019 Jul 18, 2019	SELL	$75.4 - $92.8 $28,878 - $35,542	-383 Reduced 10.57%	3,240 $296,000
Q1 2019 Apr 17, 2019	BUY	$75.32 - $86.15 $32,914 - $37,647	437 Added 13.72%	3,623 $348,000
Q4 2018 Jan 30, 2019	SELL	$73.66 - $82.02 $3,241 - $3,608	-44 Reduced 1.36%	3,186 $273,000
Q3 2018 Oct 09, 2018	SELL	$66.94 - $77.43 $7,698 - $8,904	-115 Reduced 3.44%	3,230 $278,000
Q2 2018 Jul 16, 2018	SELL	$64.91 - $73.36 $1,233 - $1,393	-19 Reduced 0.56%	3,345 $253,000
Q1 2018 Apr 16, 2018	SELL	$70.39 - $84.15 $281 - $336	-4 Reduced 0.12%	3,364 $272,000
Q4 2017 Feb 07, 2018	SELL	$72.33 - $77.64 $79,201 - $85,015	-1,095 Reduced 24.54%	3,368 $283,000
Q3 2017 Nov 01, 2017	BUY	$74.14 - $77.27 $330,886 - $344,856	4,463	4,463 $383,000

Others Institutions Holding NVS

# of Institutions

1,435

Shares Held

133M

Call Options Held

1.12M

Put Options Held

1.83M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $224B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nwam LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nwam LLC with notifications on news.

Account